June 24, 2014

On June 19, the House of Representatives' Energy & Commerce Subcommittee on Health marked up the MD-CARE Act and voted to advance the bill!

June 11, 2014

They did it again! The Bormann and Jensen families hosted fundraisers over the Memorial Day weekend and raised more than $34,000 for MDF!

June 9, 2014

Isis Pharmaceuticals, Inc. announced today that it has launched a Phase 1 clinical trial for ISIS-DMPKRX. ISIS-DMPKRX is designed to reduce the production of toxic dystrophia myotonic-protein kinase (DMPK) RNA in cells, including muscle cells, for the treatment of Myotonic Dystrophy Type 1 (DM1).